The management of acute hepatic failure
- 1 July 1971
- journal article
- review article
- Published by Oxford University Press (OUP)
- Vol. 47 (549) , 493-498
- https://doi.org/10.1136/pgmj.47.549.493
Abstract
Summary: Acute fulminant hepatitis leads to complex biochemical and circulatory disturbances including coma. These can be predicted to some extent by knowledge of the functions of the normal liver cells. Ineffective haemostasis, coma, hypoglycaemia, electrolyte abnormalities, hypotension and renal circulatory failure are particularly important. Management should be governed by the abnormalities found in the individual patient. Fluid overload and sedation must be avoided. More complex methods of temporary hepatic support such as exchange transfusion or perfusion of the isolated pig’s liver should only be considered after simpler methods of correction have been attempted for a reasonable period of time and found wanting. The prognosis of acute hepatocellular failure reaching the stage of deep coma is very poor, the mortality being about 80-90%.Keywords
This publication has 27 references indexed in Scilit:
- EXTRACORPOREAL PIG-LIVER PERFUSION IN TREATMENT OF HEPATIC COMA DUE TO FULMINANT HEPATITISThe Lancet, 1971
- Augmentation of albumin but not fibrinogen synthesis by corticosteroids in patients with hepatocellular diseaseJournal of Clinical Investigation, 1970
- INTRAVASCULAR COAGULATION IN ACUTE HEPATIC NECROSISThe Lancet, 1970
- IMMUNE COMPLEXES IN HEPATITISThe Lancet, 1969
- ACUTE HEPATIC NECROSIS WITH STUPOR OR COMA An Analysis of Thiety-One PatientsMedicine, 1969
- Effect of corticosteroid therapy on bromsulphthalein excretion in active chronic hepatitis.Gut, 1968
- HEPATIC COMA DUE TO ACUTE HEPATIC NECROSIS TREATED BY EXCHANGE BLOOD-TRANSFUSIONThe Lancet, 1967
- Heterologous Liver Perfusion in Treatment of Hepatic FailureAnnals of Surgery, 1965
- JAUNDICE AND ITS RELATION TO THERAPEUTIC AGENTSThe Lancet, 1965
- BLOOD-AMMONIUM LEVELS IN LIVER DISEASE AND "HEPATIC COMA"The Lancet, 1955